News & Events
Press Announcements
Note: Press announcements from 2004 to 2009 are available through the FDA Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
October 2014
- October 10, 2014 - FDA approves a new ultrasound imaging agent
- October 10, 2014 - FDA approves first combination pill to treat hepatitis C
- October 10, 2014 - FDA approves first drug-coated angioplasty balloon catheter to treat vascular disease
- October 10, 2014 - FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy
- October 03, 2014 - FDA seeks permanent injunction against Pharmaceutical Innovations, Inc.
- October 01, 2014 - The FDA takes steps to strengthen cybersecurity of medical devices
September 2014
- September 30, 2014 - FDA awards grants to stimulate drug, device development for rare diseases
- September 25, 2014 - U.S. Marshals seize botanical substance kratom from southern California facility
- September 25, 2014 - NIH and FDA win top award for intellectual property licensing of meningitis vaccine
- September 24, 2014 - FDA clears glucose monitoring system for use in hospital critical care units
- September 23, 2014 - FDA food safety challenge to spur new technologies for fighting foodborne illness
- September 22, 2014 - FDA allows marketing of the first test to identify five yeast pathogens directly from a blood sample
- September 19, 2014 - FDA releases updated proposals to improve food safety and help prevent foodborne illness in response to public comments
- September 18, 2014 - FDA approves Trulicity to treat type 2 diabetes
- September 16, 2014 - FDA approves Movantik for opioid-induced constipation
- September 10, 2014 - FDA approves weight-management drug Contrave
- September 09, 2014 - FDA reminds health care professionals and consumers not to use sterile products from Downing Labs/NuVision Pharmacy of Texas
- September 05, 2014 - FDA allows marketing of the first test to assess risk of developing acute kidney injury
- September 04, 2014 - U.S. Marshals seize drug products from Flawless Beauty
- September 04, 2014 - FDA approves Keytruda for advanced melanoma
August 2014
- August 25, 2014 - FDA takes action against Georgia dietary supplement manufacturer
- August 20, 2014 - FDA allows marketing of first ZnT8Ab autoantibody test to help diagnose type 1 diabetes
- August 19, 2014 - FDA approves new drug to treat a form of Gaucher disease
- August 15, 2014 - Turkish man pleads guilty to importing illegal cancer drugs
- August 14, 2014 - FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer
- August 14, 2014 - FDA warns consumers about fraudulent Ebola treatment products
- August 13, 2014 - FDA approves new type of sleep drug, Belsomra
- August 12, 2014 - FDA approves donor lung preservation device that may result in more lung transplants
- August 11, 2014 - FDA seeks permanent injunction against Michigan cheese manufacturer
- August 11, 2014 - FDA approves first non-invasive DNA screening test for colorectal cancer
- August 06, 2014 - FDA approves Orbactiv to treat skin infections
- August 01, 2014 - FDA expands approval of drug to treat Pompe disease to patients of all ages; removes risk mitigation strategy requirements
- August 01, 2014 - FDA approves Jardiance to treat type 2 diabetes
July 2014
- July 31, 2014 - FDA approves Striverdi Respimat to treat chronic obstructive pulmonary disease
- July 31, 2014 - FDA takes steps to help ensure the reliability of certain diagnostic tests
- July 29, 2014 - FDA Commissioner Margaret A. Hamburg’s Statement on the Surgeon General’s Call to Action to Prevent Skin Cancer
- July 28, 2014 - FDA expands approved use of Imbruvica for chronic lymphocytic leukemia
- July 24, 2014 - The United States and Mexico sign statement of intent to strengthen produce safety
- July 23, 2014 - FDA announces voluntary nationwide recall of all non-expired sterile drugs from Unique Pharmaceuticals
- July 23, 2014 - FDA approves new extended-release oxycodone with abuse-deterrent properties
- July 23, 2014 - FDA approves Zydelig for three types of blood cancers
- July 17, 2014 - Indictment of FedEx Corporation for Illegally Distributing Prescription Drugs
- July 17, 2014 - FDA approves new product to treat rare genetic disease
- July 16, 2014 - Update on findings in the FDA cold storage area on the NIH campus
- July 09, 2014 - United States enters consent decree with New York dietary supplement manufacturer
- July 03, 2014 - FDA approves Beleodaq to treat rare, aggressive form of non-Hodgkin lymphoma
- July 02, 2014 - Federal judge approves consent decree with New York dietary supplement maker
- July 01, 2014 - FDA seeks permanent injunction against California pharmaceutical company
- July 01, 2014 - FDA outlines expectations for human drug compounders, including registered outsourcing facilities
June 2014
- June 27, 2014 - FDA approves Afrezza to treat diabetes